The Ministry of Science & Technology has announced a major push to blend biotechnology with artificial intelligence (AI). The move aligns with the NITI Aayog’s ‘AI for All’ strategy and aims to create an ecosystem that supports health, agriculture, and industry.
Key Developments
- Launch of the BTISNet‑driven Theoretical & Computational Biology Programme across the country.
- Support for AI‑driven cancer imaging and an imaging biobank for precision diagnostics.
- Completion of the GenomeIndia project with over 10,174 whole‑genome sequences, a catalogue of 180 million variants and a biobank of more than 20,000 biospecimens.
- Establishment of the Indian Biological Data Centre (IBDC) featuring seven specialised data repositories.
- Collaboration with the Bill & Melinda Gates Foundation for the AI‑for‑Ultrasound programme under Grand Challenges India.
- Creation of Bio‑AI Hubs to provide shared biomanufacturing infrastructure and AI‑driven design tools.
- Funding through the ANRF via schemes such as Advanced Research Grant, Prime Minister Early Career Research Grant and the MAHA mission, including the AI‑SE and MAHA MedTech missions.
Important Facts
The AI‑enabled medical imaging repository now holds over 1 million radiology images and 20,000 pathology images of head‑neck cancers. AI tools have been developed for crop disease diagnosis, diabetic retinopathy screening, blood‑flow simulation, protein analysis, genome annotation and precision oncology. Under the Grand Challenges India initiative, AI‑based ultrasound models have been validated across multiple clinical sites, targeting maternal‑fetal health.
Exam Relevance
- Shows how the government integrates cutting‑edge technology with public health and agriculture, a key theme in GS3: Science & Technology.
- Highlights inter‑agency collaboration (Ministry, NITI Aayog, IITs, AIIMS, industry) – relevant for GS4: Governance.
- Data‑intensive projects like GenomeIndia and IBDC illustrate the importance of big‑data infrastructure for policy planning.
- Funding mechanisms through ANRF and MAHA reflect the government’s push for research commercialization, a topic in GS3 and GS4.
Way Forward
To maximise impact, the government should:
- Strengthen data‑sharing policies to ensure equitable access for researchers across states.
- Promote skill‑development programmes that train scientists in AI‑bioinformatics.
- Encourage public‑private partnerships that move AI‑based prototypes to market, especially in affordable diagnostics.
- Monitor ethical, privacy and equity issues in AI‑driven health solutions, aligning with the ethics framework of GS4.
These steps will help India harness AI‑enabled biotechnology for inclusive growth, better health outcomes and global scientific leadership.